Exkivity: Treating Rare Lung Cancer
Aluko Studio
Exkivity is an oral lung cancer medication developed by Takeda Pharmaceutical to treat Non-small cell lung cancer (NSCLC).
Mission
BGB Group worked on strategy, and some initial concepts while waiting for the drugs approval. I worked with them to develop launch collateral.
Outcome
I aided in the development of the look & feel including banner ads, icons, email templates and packaging.
BRANDED CVA ICONS
NOW APPROVED EMAIL
WELCOME KIT
BRANDED PLAYBOOK
Like this project
Posted Aug 15, 2023
I aided in the development of the look & feel of banner ads, icons, email templates and packaging.
Likes
0
Views
15
Clients
BGB Group
Takeda
